Approvals/CIMA-AEMPS/ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Approved

STANDARD

ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Otsuka Pharmaceutical Netherlands B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: e24b7ef0151adcf4
Drug Cima Aemps Name: ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Register Number: 113882002IP1
Holder Company Name: Otsuka Pharmaceutical Netherlands B.V.
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/otsuka-pharmaceutical-netherlands-b-v
Authorization Date: 2023-11-03
Dosage Form: SUSPENSION INYECTABLE DE LIBERACION PROLONGADA
Dose: 400 mg
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Otsuka Pharmaceutical Netherlands B.V.
Company Detail Path: /organization/otsuka-pharmaceutical-netherlands-b-v

ARIPIPRAZOL

400 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 3, 2023

Approval ID

e24b7ef0151adcf4

Type

Standard